Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J V Heymach

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Current Opinion in Oncology|June 29, 2001
Angiogenesis and antiangiogenic approaches to sarcomasJ V Heymach
British Journal of Cancer|June 2, 2005
ZD6474--clinical experience to dateJ V Heymach
The Journal of Biological Chemistry|May 19, 1995
The biosynthesis of neurotrophin heterodimers by transfected mammalian cellsJ V Heymach, E M Shooter
Nature|March 30, 1995
Neurobiology. Neuronal self-relianceJ V Heymach, B A Barres
Nature|February 12, 1998
Neurotrophins moving forwardJ V Heymach, B A Barres
The EMBO Journal|September 11, 1991
Two conserved domains in the NGF propeptide are necessary and sufficient for the biosynthesis of correctly processed and biologically active NGFU Suter, J V Heymach, E M Shooter
The Journal of Biological Chemistry|October 11, 1996
The regulated secretion and vectorial targeting of neurotrophins in neuroendocrine and epithelial cellsJ V Heymach, A Krüttgen, U Suter, et al.
The Journal of Biological Chemistry|November 20, 1997
The role of the nerve growth factor carboxyl terminus in receptor binding and conformational stabilityA Krüttgen, J V Heymach, P J Kahle, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 1998
Neurotrophins induce release of neurotrophins by the regulated secretory pathwayA Krüttgen, J C Möller, J V Heymach, et al.
ESMO Open|January 28, 2026
Treatment options and considerations for acquired resistance in EGFR mutation-positive non-small-cell lung cancerX Le, S Popat, J V Heymach, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Current Opinion in Oncology|June 29, 2001
Angiogenesis and antiangiogenic approaches to sarcomasJ V Heymach
British Journal of Cancer|June 2, 2005
ZD6474--clinical experience to dateJ V Heymach
The Journal of Biological Chemistry|May 19, 1995
The biosynthesis of neurotrophin heterodimers by transfected mammalian cellsJ V Heymach, E M Shooter
Nature|March 30, 1995
Neurobiology. Neuronal self-relianceJ V Heymach, B A Barres
Nature|February 12, 1998
Neurotrophins moving forwardJ V Heymach, B A Barres
The EMBO Journal|September 11, 1991
Two conserved domains in the NGF propeptide are necessary and sufficient for the biosynthesis of correctly processed and biologically active NGFU Suter, J V Heymach, E M Shooter
The Journal of Biological Chemistry|October 11, 1996
The regulated secretion and vectorial targeting of neurotrophins in neuroendocrine and epithelial cellsJ V Heymach, A Krüttgen, U Suter, et al.
The Journal of Biological Chemistry|November 20, 1997
The role of the nerve growth factor carboxyl terminus in receptor binding and conformational stabilityA Krüttgen, J V Heymach, P J Kahle, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 1998
Neurotrophins induce release of neurotrophins by the regulated secretory pathwayA Krüttgen, J C Möller, J V Heymach, et al.
ESMO Open|January 28, 2026
Treatment options and considerations for acquired resistance in EGFR mutation-positive non-small-cell lung cancerX Le, S Popat, J V Heymach, et al.
Pageof 4